Simultaneously, the mRNA level of Hes5 and Glast, two markers highly expressed in NSCs were also decreased, while that of Mash1, a marker up-regulated in INPs was increased in primary tumor spheres after being treated with GSI [20]. The gene discussed is SLC1A3; the disease is neoplasm.